Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Now we have doubled our insecure future

"I personally think it a waste for RG to go to NY without releasing the Crossflo financials first. Obviously the investment community was unimpressed as there certainly was no increase in volume since the conference"

This is something, which puzzles me since the start of Ibis looking for new investors in August:

If they and RG are telling the same story/things to potential investors they are telling the public - what the heck do they expect?

Who in the world would invest in a company, which paid 10mio (actually 6mio with the loss of the shares) for a company with such a money burn rate? Of course it's all about Crossflo's future, but where do we see this future besides "nice words"?

If RG is as professionell in communications as he is in other business areas, he shouldn't be "dumbfounded" by the current situation - he should know 100%, why we are where we are.

After the release of the Crossflo numbers (though they are "old" in terms of the possible developments in the last months) we face two huge uncertainties:

1. the power of the MMP - as long as the USPTO is quiet, the market doesn't know, how strong the MMP is finance wise

2. the strength of the Crossflo solution - as long as the market doesn't know, what additional products are going to be build around the Crossflo products and if they are accepted by potential customers, the outcome of the Crossflo acquisition is uncertain

I'm afraid, we won't see a positive change in the next months...glta


Share
New Message
Please login to post a reply